167 related articles for article (PubMed ID: 28707493)
21. Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC.
Klavž J; Gorenjak M; Marinšek M
Forensic Sci Int; 2016 Aug; 265():121-4. PubMed ID: 26890319
[TBL] [Abstract][Full Text] [Related]
22. Concentrations of AB-CHMINACA and AB-PINACA and Driving Behavior in Suspected Impaired Driving Cases.
Peterson BL; Couper FJ
J Anal Toxicol; 2015 Oct; 39(8):642-7. PubMed ID: 26378139
[TBL] [Abstract][Full Text] [Related]
23. Synthetic cannabinoids: Variety is definitely not the spice of life.
Langford AM; Bolton JR
J Forensic Leg Med; 2018 Oct; 59():36-38. PubMed ID: 30130700
[TBL] [Abstract][Full Text] [Related]
24. The 2-alkyl-2
Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M
Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266
[TBL] [Abstract][Full Text] [Related]
25. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
Kevin RC; Wood KE; Stuart J; Mitchell AJ; Moir M; Banister SD; Kassiou M; McGregor IS
J Psychopharmacol; 2017 Jun; 31(6):757-769. PubMed ID: 28093016
[TBL] [Abstract][Full Text] [Related]
26. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
Lam RPK; Tang MHY; Leung SC; Chong YK; Tsui MSH; Mak TWL
Clin Toxicol (Phila); 2017 Aug; 55(7):662-667. PubMed ID: 28393558
[TBL] [Abstract][Full Text] [Related]
27. Do you feel it now? Route of administration and Δ
Wiley JL; Lefever TW; Glass M; Thomas BF
Neurotoxicology; 2019 Jul; 73():161-167. PubMed ID: 30953678
[TBL] [Abstract][Full Text] [Related]
28. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
[TBL] [Abstract][Full Text] [Related]
29. Metabolites of synthetic cannabinoids in hair--proof of consumption or false friends for interpretation?
Franz F; Angerer V; Hermanns-Clausen M; Auwärter V; Moosmann B
Anal Bioanal Chem; 2016 May; 408(13):3445-52. PubMed ID: 26935933
[TBL] [Abstract][Full Text] [Related]
30. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
[TBL] [Abstract][Full Text] [Related]
31. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
[TBL] [Abstract][Full Text] [Related]
33. Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - Potential impact on therapeutic decisions.
Franz F; Haschimi B; King LA; Auwärter V
Drug Test Anal; 2020 Mar; 12(3):391-396. PubMed ID: 31944614
[TBL] [Abstract][Full Text] [Related]
34. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.
Adams AJ; Banister SD; Irizarry L; Trecki J; Schwartz M; Gerona R
N Engl J Med; 2017 Jan; 376(3):235-242. PubMed ID: 27973993
[TBL] [Abstract][Full Text] [Related]
35. Assessment of types of synthetic cannabinoids in narcotic cases assessed by the Council of Forensic Medicine between 2011-2015, Ankara, Turkey.
Göl E; Çok İ
Forensic Sci Int; 2017 Nov; 280():124-129. PubMed ID: 29028489
[TBL] [Abstract][Full Text] [Related]
36. Death after use of the synthetic cannabinoid 5F-AMB.
Shanks KG; Behonick GS
Forensic Sci Int; 2016 May; 262():e21-4. PubMed ID: 27017174
[TBL] [Abstract][Full Text] [Related]
37. Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use.
Paul ABM; Simms L; Amini S; Paul AE
J Forensic Sci; 2018 Jul; 63(4):1321-1324. PubMed ID: 29194599
[TBL] [Abstract][Full Text] [Related]
38. Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA.
Simon G; Tóth D; Heckmann V; Kuzma M; Mayer M
Leg Med (Tokyo); 2022 Feb; 54():102004. PubMed ID: 34952451
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and circumstances of synthetic cannabinoid-related death.
Darke S; Duflou J; Farrell M; Peacock A; Lappin J
Clin Toxicol (Phila); 2020 May; 58(5):368-374. PubMed ID: 31389266
[No Abstract] [Full Text] [Related]
40. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
Canazza I; Ossato A; Vincenzi F; Gregori A; Di Rosa F; Nigro F; Rimessi A; Pinton P; Varani K; Borea PA; Marti M
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
